Benzodepa

This classification denotes an ethylenimine compound with the molecular formula C12H16N3O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q30T24YM3F, chemically known as carbamic acid, (bis(1-aziridinyl)phosphinyl)-, phenylmethyl ester but more generally known as benzodepa, which bears US NIH Compound Identifier 16111. European Medicines Agency schedules Benzodepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05758MIG. The term BENZODEPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BENZODEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benzodepa under HS 29339990 and SITC 51577. As of Q4 2014, BENZODEPA remains US FDA's Preferred Term for this commodity. Benzodepa bears US NLM identifiers UMLS ID C0608440 and NCI Concept Code C1759. SMILES: C1CN1P(=O)(NC(=O)OCC2=CC=CC=C2)N3CC3.